Background Social anxiety disorder—a chronic and naturally unremitting disease that
causes substantial impairment—can be treated with pharmacological, psychological, and …

Background Inhaled corticosteroids (ICS) are anti‐inflammatory drugs that have proven
benefits for people with worsening symptoms of chronic obstructive pulmonary disease …

Background Despite its proven efficacy in improving symptoms and reducing exacerbations,
many patients with asthma are not fully adherent to their steroid inhaler. Suboptimal …

Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a
network meta‐analysis - Kew, KM - 2014 | Cochrane Library Skip to Content Cookies Our site …

Background Chronic obstructive pulmonary disease (COPD) is a respiratory disease that
causes progressive symptoms of breathlessness, cough and mucus build‐up. It is the fourth …

Background Asthma guidelines aim to guide health practitioners to optimise treatment for
patients to minimise symptoms, improve or maintain good lung function, and prevent acute …

Background Asthma guidelines aim to guide health practitioners to optimise treatment for
patients so as to minimise symptoms, improve or maintain good lung function, and prevent …

Background Asthma is characterised by chronic inflammation of the airways and recurrent
exacerbations with wheezing, chest tightness and cough. Treatment with inhaled steroids …

Background Maintenance treatment with long‐acting beta 2‐agonists and inhaled
corticosteroids (LABA/ICS) can relieve asthma symptoms and reduce the frequency of …

Background Asthma guidelines guide health practitioners to adjust treatments to the
minimum level required for asthma control. As many people with asthma have an …